Cargando…
Markov Modeling Analysis of Health and Economic Outcomes of Therapy With Valsartan Versus Amlodipine in Patients With Type 2 Diabetes and Microalbuminuria
OBJECTIVES: To estimate 8-year health and economic outcomes of the angiotensin II receptor blocker valsartan versus the calcium channel blocker amlodipine in therapy of patients with type 2 diabetes and microalbuminuria based on clinical endpoints from a 6-month randomized controlled clinical trial,...
Autores principales: | Smith, Dean G., Nguyen, Anh B., Peak, Corey N., Frech, Feride H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437959/ https://www.ncbi.nlm.nih.gov/pubmed/14720103 http://dx.doi.org/10.18553/jmcp.2004.10.1.26 |
Ejemplares similares
-
Patient Adherence With Amlodipine, Lisinopril, or Valsartan Therapy in a Usual-Care Setting
por: Wogen, Jennifer, et al.
Publicado: (2003) -
Simultaneous Determination of Amlodipine and Valsartan
por: Mohamed, Nashwah Gadallah
Publicado: (2011) -
Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015) -
Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension
por: Aabed, Wafa' J., et al.
Publicado: (2021) -
Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
por: Sung, Jidong, et al.
Publicado: (2016)